Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Medtech (Hangzhou) Inc. has announced its 2024 Second Extraordinary General Meeting, set to take place on December 5, 2024. Key resolutions include the election of Mr. John Junhua Gu as an independent non-executive director and proposed amendments to the company’s Articles of Association. Shareholders are encouraged to participate and vote on these significant decisions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.